Document is current
Any future updates will be listed below
-
Authors
Henrich, Luise
Kiessling, Iva
Steimer, Matti
Frase, Sibylle
Kaiser, Sandra
Schallner, Nils
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 26 June 2023
Accepted: 13 December 2023
First Online: 16 December 2023
Declarations
:
: All procedures involving the animals were approved by the Committee of Animal Care of the University of Freiburg (Permit No. G18/17 and No. X-18/04F) and conducted in accordance with the ARRIVE guidelines. The study protocol involving SAH patients was approved by the Institutional Ethics Review Board of the University of Freiburg (Protocol No. 293/15). Informed consent from the patient (SAH patients and patients for inter-individual reference for mRNA expression analysis), legal guardian or by proxy was provided. The trial was registered with the German Clinical Trials Register (Trial-ID DRKS00008981; Universal Trial Number U1111-1172-6077).
: Not applicable.
: The authors declare that they have no competing interests.
